PHOENIX, Feb. 17, 2012 /PRNewswire-iReach/  -- Apothecary Shop Wholesale, Inc., an affiliate of The Apothecary Shops Specialty Pharmacies, has received exclusive distribution rights from Mobius Therapeutics, LLC for its new drug Mitosol® (mitomycin for solution) 0.2 mg/vial Kit for Ophthalmic Use.
The Mitosol® Kit for Ophthalmic Use provides ophthalmic surgeons a new means of delivering a precise dose of its active ingredient, mitomycin-c, for use in glaucoma surgical procedures, without requiring a change to existing surgical technique. Last week, Mitosol® was approved by the Food and Drug Administration for use in as an antimetabolite indicated as an adjunct to ab externo glaucoma surgery. ( See full prescribing information at )
"The approval of Mitosol® for use in glaucoma surgery represents the culmination of years of work on the part of Mobius Therapeutics™," said Ed Timm, President of Mobius Therapeutics™. "It will provide surgeons, hospitals and patients with enhanced convenience, safety and consistency in the surgical treatment of glaucoma."
Since opening its first location in Arizona in 1996, The Apothecary Shops has focused on specific disease states, including ophthalmology, and has vast experience in providing medications for patients with eye-related illnesses and diseases. To best serve their patients, The Apothecary Shops has a dedicated ophthalmology sales and pharmacist team, VAWD Accreditation, and a wholesale division for office ordering.
"The Apothecary Shops is the ideal partner to distribute Mitosol®," said Ed Timm, President and CEO of Mobius Therapeutics. "Their expertise and deep understanding of ophthalmology combined with exceptional customer service levels gives us great confidence in their ability to provide the market an uninterrupted